PURPOSE
Powering precision medicine.
Velsera connects healthcare and life sciences to reveal the true promise of precision medicine—a continuous flow of knowledge between researchers, scientists and clinicians around the world, creating insights that radically improve human health.
We power this ecosystem of insight with data made actionable by AI and technology solutions that accelerate R&D, democratize omics and provide bedside analytics to improve patient outcomes.
Stay in the loop with product and service updates as we create a new era of medicine powered by Velsera—the precision engine company.
VALUE LOOP
Driving perpetual innovation.
When knowledge flows freely between the clinical realm and R&D, a network effect arises: research discoveries translate to diagnostics, and patient outcomes inform new breakthroughs.
This virtuous cycle drives what we call the value loop—iterative learning and technology-enabled solutions that support all points in the healthcare continuum.
Clinical
R&D
Sample
Our technology manages and orchestrates the flow of patient samples using cutting-edge tracking and tracing to guard the quality of data and maximize its use for research and diagnostics.
Analyze
We apply AI and machine learning software to automate the analysis of multiple testing modalities, producing results that are qualitative, accurate and amenable for clinical annotation and reporting.
Annotate
We equip researchers and clinicians with relevant information for diagnosis, therapy selection, monitoring and response prediction.
Report
Our teams curate a continuously growing knowledge base that effectively democratizes omics, providing unparalleled access to data and clinical information for accurate and up-to-date reporting.
Aggregate
We aggregate clinical information and its underlying raw data to provide a multi-omic view that enhances data from clinical trials and research studies, leveraging insight from both sides of the loop.
Integrate
Our broad expertise integrating diverse data sets provides the tools and services needed to make data work together, unlocking unprecedented insights that make joint discovery possible.
Explore
Comprehensive clinical and research omic knowledgebases can be accessed independently or in conjunction with Velsera experts, with AI and machine learning performing intelligent, deep analyses that yield actionable insights.
Generalize
These data-driven insights drive precision R&D, improve drug discovery and clinical trials as well as inform routine diagnostics — closing the loop and setting the standard for omics-based healthcare.
Sample
Our technology manages and orchestrates the flow of patient samples using cutting-edge tracking and tracing to guard the quality of data and maximize its use for research and diagnostics.
Analyze
We apply AI and machine learning software to automate the analysis of multiple testing modalities, producing results that are qualitative, accurate and amenable for clinical annotation and reporting.
Annotate
We equip researchers and clinicians with relevant information for diagnosis, therapy selection, monitoring and response prediction.
Report
Our teams curate a continuously growing knowledge base that effectively democratizes omics, providing unparalleled access to data and clinical information for accurate and up-to-date reporting.
Aggregate
We aggregate clinical information and its underlying raw data to provide a multi-omic view that enhances data from clinical trials and research studies, leveraging insight from both sides of the loop.
Integrate
Our broad expertise integrating diverse data sets provides the tools and services needed to make data work together, unlocking unprecedented insights that make joint discovery possible.
Explore
Comprehensive clinical and research omic knowledgebases can be accessed independently or in conjunction with Velsera experts, with AI and machine learning performing intelligent, deep analyses that yield actionable insights.
Generalize
These data-driven insights drive precision R&D, improve drug discovery and clinical trials as well as inform routine diagnostics — closing the loop and setting the standard for omics-based healthcare.
EXPERTISE
Delivering value from discovery to diagnostics.
Velsera unites established, leading companies from healthcare and life sciences to advance and accelerate the work of both domains. All companies will remain actively engaged with existing customers, enhance current offerings, accelerate new offerings and bring integrated solutions to market as the leading provider of global omics and insights.
The vision for Velsera is supported by Summa Equity, a purpose-driven investment firm advancing precision health through data-driven solutions.
-
UgenTec brings sample flow intelligence to advance modern molecular diagnostics across routine and research applications. UgenTec software and AI solutions deliver workflow automation, result calling at scale and real-time insights for the digital, connected lab.
SAMPLE FLOW INTELLIGENCE:- ~100M clinical test results automated on FastFinder.
- Hundreds of sample-to-result workflows deployed across lab, assay and instrument partners.
- FastFinder automated over 1/3 of all COVID-19 testing in Europe.
-
Pierian is a global leader in clinical genomics technology and services supporting a network of laboratories around the globe. Pierian curates the world’s genetic knowledge and offers sophisticated analysis tools to allow for rapid, concise clinical reporting. Its advanced interpretation technology uses adaptive learning algorithms to connect diverse sources of information through machine learning to ensure NGS results are comprehensive and up to date.
PRECISION IN PRACTICE:- Over 6M sequences covered in the human genome, with 350,000+ inferencing rules.
- Updated curated content, with 1,250 somatic genes curated.
- Extensive sequence coverage: more than 53MB.
-
Seven Bridges enables researchers to extract meaningful insights from multiomic, phenotypic and other high throughput data modalities. The Seven Bridges ecosystem consists of a scalable, secure multi-cloud analytic platform, petabytes of connected biomedical data and expert on-demand professional services.
INFORMATICS FOR ALL:- 16K+ global researchers collaborating with federated data sets and transformative algorithms.
- Trusted by 9 out of 10 top biopharma as well as national governments to power secure discovery using health and omics data.
- Pioneer of graph-based algorithms to democratize genomics for individuals of all ancestries.
LEADERSHIP
Founded on diverse expertise.
Gavin Nichols
Chief Executive Officer
Gavin has 30+ years of success in strategy and operations. He was most recently CEO of Calyx, and prior to Calyx, Gavin was a life science practice partner at Unisys. He spent >10 years at Quintiles covering divisions such as Advanced Analytics, Innovation R&D, Customer Alliances and Partnerships.
Tres Thompson
Chief Financial Officer
Tres has FP&A, operations, sales and business development experience in FinTech and Healthcare IT, along with extensive M&A leadership experience. Prior to joining Velsera, he spent nearly 6 years as CFO and COO of symplr, a leading healthcare credentialing and compliance software company. Prior to that, he spent nearly 11 years at Cardtronics.
Brandi Davis-Dusenbery, PhD
Chief Science Officer
Dr. Davis-Dusenbery brings exceptional scientific acumen to the Velsera team. As the former CSO and CEO of Seven Bridges, she led the development of collaborative data analysis and standards. She is published in leading scientific journals, including Nature and Cell.
Lindsay Mateo
Chief Commercial Officer
Lindsay brings deep experience in business development, sales, marketing and commercial strategy and operations to Velsera. She was the Chief Business Officer at Pierian, and has held leadership roles at Tempus and Navican, an Intermountain Company. Lindsay also spent 11 years in leadership at Genoptix focused on oncology diagnostics.
Rakesh Nagarajan, MD, PhD
Chief Medical Officer
Dr. Nagarajan has been a pioneer in genomics for 20+ years. He started at Washington University, the first CAP/CLIA laboratory for clinical NGS. As the Founder and President of Pierian, he built the Clinical Genomics Workspace, and will now incubate and develop technology solutions to extend Velsera’s reach.
Wouter Uten
Chief Product Officer
Wouter is an entrepreneur with a foundation in bioinformatics. As the co-founder and COO of UgenTec, he developed the company into a global leader in molecular laboratory workflow automation. At Velsera, Wouter will enhance existing offerings and lead planning and development of new solutions.
Debbie Thompson
Chief People Officer
Debbie is a people-first executive with experience in high growth organizations. She was the Chief People Officer at Pierian, and prior to that held leadership roles at BoundlessGeo, Lumeris, and Essence Healthcare. Debbie’s track record in scaling technology-enabled companies will be key to continued global expansion for Velsera.
Steven Verhoeven
Chief Operating Officer
Steven has strong operational experience in enterprise software organizations. Previously he was the CEO at UgenTec where he developed the company into a global leader in molecular workflow automation. He also led informatics strategy and operations at Agilent Technologies and was COO at Cartagenia.
John Patrick
Chief Technology Officer
JP brings extensive experience in product development, software engineering and secure cloud hosting to Velsera. Most recently he was the EVP of Engineering at TalentReef, and beforehand he was the SVP of Product Development and Cloud Hosting Services at Bioclinica.
Kamraan Shariff
Chief Corporate Development Officer
Kamraan has 25+ years of experience in M&A and joint ventures, venture capital and investment banking. In addition to senior leadership roles at GE Ventures and GE Corporate Development/M&A, Kamraan was Chief Business Development Officer for Congenica and Head of Corporate Development at Drawbridge Health.
Stay in the loop.
Keep up with new products, services and enhancements to the offerings of our constituent companies as we become Velsera—the precision engine company.